Ivacaftor + Tezacaftor

Category: Genetic Disorders

Ivacaftor + Tezacaftor Overview

Tezacaftor, also known as VX-661, is a drug approved by the FDA to treat some cases of cystic fibrosis. In 2018, the FDA approved a combination of ivacaftor and tezacaftor; the manufacturer announced a list price of $292,000 per year.[1] The combination of ivacaftor and tezacaftor is being sold as Symdeko.[2] Contents 1 Mechanism of action 2 Properties 3 Clinical trials 4 References Mechanism of action Tezacaftor helps move the CFTR protein to the corr...

Read more Ivacaftor + Tezacaftor Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Tezacaftor

Recent Ivacaftor + Tezacaftor Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Ivacaftor + Tezacaftor
  • Tablet, Tablet: 150mg,n/a + 150mg, 100mg, 75mg,n/a + 75mg, 50mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Drugs with one or more similar ingredients: (5 results)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 18 October 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA